2 Year Efficiency and Safety Comparison of Insulin Detemir and NPH Insulin [insulin-suspension-isophane] in Type 1 Diabetes.

Trial Profile

2 Year Efficiency and Safety Comparison of Insulin Detemir and NPH Insulin [insulin-suspension-isophane] in Type 1 Diabetes.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Feb 2017

At a glance

  • Drugs Insulin detemir; Insulin suspension isophane
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 07 Jul 2009 Actual patient number changed from 497 to 501 as reported by ClinicalTrials.gov.
    • 07 Jul 2009 Actual end date (Sep 2006) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top